EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances

Hongyun Mao, Jing Hu, Chenshuo Yu, Sicong Xie, Cheng Chang, Juanjuan Peng, Yang Zhang

Frontiers in Cardiovascular Medicine · 22.08.2025 · 12

DOI: 10.3389/fcvm.2025.1614878 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.08.2025. Verfasst von Hongyun Mao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, School of Acupuncture-Moxibustion and Tuina and School of Health Preservation and Rehabilitation, Nanjing Univ…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anthracycline-based chemotherapy is a highly effective treatment for numerous cancers, yet its clinical use is severely limited by cumulative, dose-dependent cardiotoxicity. MicroRNAs (miRNAs), as key post-transcriptional regulators of gene expression, play a pivotal role in the pathophysiology of cardiovascular disease, but their specific functions in anthracycline-induced cardiotoxicity (AIC) require systematic elucidation.

Purpose

This review aims to systematically summarize current research on the key miRNAs, their molecular targets, and associated signaling pathways that regulate AIC, while also exploring their potential as biomarkers for early diagnosis and as therapeutic targets for intervention.

Methods

A comprehensive literature search was conducted in PubMed, Web of Science, and Scopus databases for relevant studies published up to April 2025. Search terms included combinations of “microRNA,” “anthracycline,” “doxorubicin,” “cardiotoxicity,” and “cardiomyopathy.” Results A complex network of miRNAs is involved in the regulation of AIC. Pro-toxic miRNAs, such as miR-34a and miR-146a, exacerbate cardiomyocyte apoptosis and oxidative stress by targeting Sirtuin 1 (SIRT1) and anti-apoptotic proteins. In contrast, cardioprotective miRNAs, such as miR-21 and miR-133a, mitigate cardiac injury by inhibiting fibrosis and apoptosis pathways. This network dynamically influences the onset and progression of AIC, affecting key processes including oxidative stress, autophagy, fibrosis, and apoptosis.

Conclusion

MiRNAs play a dual role in the pathomechanisms of AIC, acting as both pathogenic factors and protective agents. A deeper understanding of this regulatory network provides a solid theoretical foundation for developing novel miRNA-based diagnostic biomarkers and intervention strategies to manage AIC. Future research should focus on validating clinical biomarker panels and optimizing targeted delivery systems.

Schlagwörter

Stichwörter der Autor:innen

anthracyclinebiomarkercardiotoxicitymechanismsmicroRNAs

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, School of Acupuncture-Moxibustion and Tuina and School of Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, China.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Neurosurgery, NanJing JiangNing Hospital of Chinese Medicine and Affiliated Jiangning Hospital of Chinese Medicine, China Pharmaceutical University, Nanjing, China.
  • Department of Cardiology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China.

Zitieren

APA

Mao, H., Hu, J., Yu, C., Xie, S., Chang, C., Peng, J., & Zhang, Y. (2025). MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1614878

Vancouver

Mao H, Hu J, Yu C, Xie S, Chang C, Peng J, et al. MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1614878

BibTeX
@article{Mao2025,
  author = {Mao, Hongyun and Hu, Jing and Yu, Chenshuo and Xie, Sicong and Chang, Cheng and Peng, Juanjuan and Zhang, Yang},
  title = {MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1614878}
}
Kostenlos starten →